Table: begin end state 1 19 non-cytoplasmic 20 49 transmembrane 50 60 cytoplasmic 61 82 transmembrane 83 108 non-cytoplasmic 109 135 transmembrane 136 146 cytoplasmic 147 163 transmembrane 164 168 non-cytoplasmic 169 188 transmembrane 189 199 cytoplasmic 200 224 transmembrane 225 258 non-cytoplasmic 259 280 transmembrane 281 315 cytoplasmic 316 337 transmembrane 338 355 non-cytoplasmic 356 380 transmembrane 381 390 cytoplasmic 391 411 transmembrane 412 416 non-cytoplasmic 417 443 transmembrane 444 463 cytoplasmic 464 488 transmembrane 489 505 non-cytoplasmic
Input: >SM_b20726 MGTFDFLLQGLLVAAQPMNLLYALIGVTLGTAVGVLPGIGPALTVALLLPVTYQLDPAGS LIMFAGIYYGGMYGGSTTSILLNTPGESASIVTALEGNKMARAGRGGPALATAAIGSFVA GLIATLGLAFIAPYIVKLALVFGPREYFALMVLAFVTVSSAFGDSTLRGLTSLFIGLTLA CIGIDQLTGQARLSFGVPDLLDGIEVTTLAVAMFAIGETLFIAAQGDRGPDKVEAVRGSV WMSATDWARSWKPWLRGTFIGFPIGAMPAGGAEIGTFLSYAAEKRLTKHPEEFGNGAIEG VAGPEAANNASAAGTLVPLLTLGLPTTATAAIMLAGFQQYGLQPGPLLFATNPQLVWGLI ASLLIANFMLLVLNLPLIGLWVKLLTIPKPWLYAGILLFATLGTIGANPSVFELGMLLAF GLLGYVMRVFGYPIAPVVVGLILGPLAEQQLRRALSISQGDITVLFTSPIAAVLLVIAAL ALVVPLILRARGRGEVLAQLAASED
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server